Breadcrumb

Antonios Papanicolau-Sengos, M.D.

Antonios Papanicolau-Sengos, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Laboratory of Pathology

RESEARCH SUMMARY

Dr. Papanicolau-Sengos left CCR in December 2023. He is a molecular pathologist. He is interested in targeted oncotherapeutics, the molecular classification of neoplasms, and machine learning applications in molecular pathology

Areas of Expertise

Neoplasm Molecular Genomics
Epigenetic Oncology

Publications

Selected Recent Publications

Identification of targets for prostate cancer immunotherapy

Papanicolau-Sengos A, Yang Y, Pabla S, Lenzo FL, Kato S, Kurzrock R, DePietro P, Nesline M, Conroy J, Glenn S, Chatta G, Morrison C.
Prostate. 79(5): 498-505, 2019. [ Journal Article ]

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

Conroy JM, Pabla S, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Wang Y, Lenzo FL, Bshara W, Khalil M, Dy GK, Madden KG, Shirai K, Dragnev K, Tafe LJ, Zhu J, Labriola M, Marin D, McCall SJ, Clarke J, George DJ, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, de la Cruz- Merino L, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Kasuganti D, Shah N, Day R, Galluzzi L, Gardner M, Morrison C.
J Immunother Cancer. 7(1): 18, 30678715. [ Journal Article ]

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, Yirong W, Dy GK, Yau E, Early A, Chen H, Bshara W, Madden KG, Shirai K, Dragnev K, Tafe LJ, Marin D, Zhu J, Clarke J, Labriola M, McCall S, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Dressler L, Steciuk M, Binns O, Kasuganti D, Shah N, Ernstoff M, Odunsi K, Kurzrock R, Gardner M, Galluzzi L, Morrison C.
J Immunother Cancer. 7(1): 27, 2019. [ Journal Article ]